Delivery Order SPE2DB22D1017-SPE2DB24FF9YU
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,250.23, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 21, 2024. The award was not designated with a set-aside requirement, indicating...
This federal contract award is for the supply of OPZELURA 1.5% cream (60g) to the Defense Logistics Agency (DLA). The $6,153.92 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a completion date of July 25, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical to...
This federal contract award is for the delivery of OPZELURA 1.5% Cream 60GM to the Defense Logistics Agency (DLA), a defense agency. The $1,250.23 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of November 19, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of OPZELURA 1.5% cream in 60g units to the U.S. Department of Defense (DoD) by Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,500.46, is a Firm Fixed Price Delivery Order with a completion date of June 25, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical worth up to $999,999,999.00...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a $7,401.46 firm-fixed-price delivery order for the pharmaceutical product OPZELURA 1.5% Cream 60GM. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 20, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,919.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OPZELURA 1.5% Cream 60GM. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This federal contract award, valued at $5,778.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a period of performance through October 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there is no set-aside designation indicated. Amerisourcebergen...
This federal contract award is for the delivery of OPZELURA 1.5% cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price ceiling value of $5,395.50 and a completion date of February 1, 2024. The contract was awarded through full and open competition, with no set-aside designation....
This federal contract award is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,165.32 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 20, 2024, with a completion date of November 21, 2024. The contract is not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,555.32 contract is for the delivery of OPZELURA 1.5% Cream, a prescription pharmaceutical product. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...